International Life Sciences Awards 2017

16 GHP / International Life Sciences Awards 2017 , Dedicated to delivering expert services to life science organisations, Sciformix employs strategies, technologies and expertise that accelerates business, drives higher levels of performance and fosters innovation. Its mission is to partner with global life science companies to provide high quality scientific expertise and innovative solutions that deliver better quality outcomes and improved efficiencies across the entire product lifecycle with the ultimate objective of improving the quality of healthcare to patients worldwide. Chitra discusses, below, the firm’s specific focus within their industry. “When Sciformix was formed 10 years ago, we sought to fill a gap in the industry and set the vision of establishing a company to provide specialised science- based services to life science organisations in a global delivery model. Our Safety & Risk Management and Biometrics offerings progressively expanded to include Medical Writing and Regulatory Affairs to support our clients’ growing needs. The company later introduced Clinical Research and Post Approval Support Services, greatly Most Innovative Global Scientific Process Organization and Excellence Award for Signal Detection & RiskManagement 2017 Sciformix is a leading scientific knowledge-based organisation that provides process, technology and consulting services.We invitedDr Chitra Lele, Chief Scientific Officer, to tell us a bitmore about the firmand the innovative solutions that it offers. expanding our offerings and expertise in clinical trial conduct and the post-marketing phase. As the market and industry have evolved we introduced Technology Services and Real World Evidence & Market Access services. The company has over 1,000 employees around the world and is acclaimed for its depth of scientific expertise, specifically its ability to recruit staff with many years of industry experience within the domains that we support.” Regarding its services and how the firm sets itself aside from its competitors, Chitra notes that Sciformix is able to delivery higher quality and compliant deliverables along with greater insight to its clients by employing a flexible and agile delivery model. “A significant capability that sets us apart is our ability to integrate our scientific and technology expertise with quality driven processes to provide value to our clients throughout the entire drug development cycle. We deliver consistent quality and compliance across our services by employing scientific rigor in combination with streamlined process, optimal technology and efficient people practices. Clients benefit from our global cost and resource-optimized business model, affording them the flexibility and scalability to tap into a worldwide pool of talent with a diverse skill-set across the US, Europe, India and the Philippines.” In an increasingly technology orientated industry, the firm incorporates technology into its services and processes, enabling it to deliver higher levels of compliance and quality to its clients. Chitra outlines how this will have a positive impact on product lifecycle management. “Technology has forever transformed the entire healthcare continuum and has ushered in new and revolutionary ways to collect and analyse data more efficiently. One of the biggest challenges organisations face is how to effectively integrate the science behind all aspects of the product lifecycle with the technology know-how behind it. Companies that recognise the importance of an integrated strategy that takes these two elements into consideration, and adapts it to the changing global regulatory landscape, will see greater success in managing the lifecycles of their products. LI170014 Excellence Award for Signal Detection & Risk Management 2017 “As one of the leading global providers of Safety & Risk Management and Regulatory services, Sciformix is uniquely positioned to combine this rich knowledge with our customised IT solutions. Our integrated drug safety solutions help life science companies build Pharmacovigilance (PV) IT reference architecture, deploy signal detection applications and create enterprise portals for safety analytics. The environment has evolved in recent years from being almost entirely focused on the operational aspects of drug safety to a greater demand for support from partners in aggregate reporting and signal detection. Our ability to combine domain-specific know-how with IT services has been key to successfully evolving our business and meeting our clients’ needs. We have proprietary tools to manage the safety data workflow, to manage literature search, review and documentation for literature case processing and to apply signal detection algorithms for our client projects.”